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143 The social network in cystic ﬁbrosis centre care and the risk of
shared Pseudomonas aeruginosa strain infection
T.J. Kidd1, R.J. Soares Magalha˜es2, S. Paynter2, S.C. Bell1,3, the ACPinCF
Investigator Group. 1Queensland Children’s Medical Research Institute, The
University of Queensland, Brisbane, Australia; 2The University of Queensland,
School of Population Health, Brisbane, Australia; 3The Prince Charles Hospital,
Thoracic Medicine, Brisbane, Australia
Background: During a recent national prevalence study of 983 Australian cystic
ﬁbrosis (CF) patients two predominant Pseudomonas aeruginosa genotypes, AUST-
01 and AUST-02, were identiﬁed in 22% and 18% patients, respectively. It is unclear
whether patient movement plays a role in the distribution and prevalence of these
strains.
Objectives: To explore prior patient movement between Australian CF centres and
to describe and visualise the network characteristics of AUST-01 and AUST-02
infection.
Methods: Patient movements were analysed using social network analysis, using
a 2-mode network and two 1-mode networks (patients linked to other patients via
a common centre and a network of centres linked to other centres via a common
patient). Network connectivity included estimations of degree centrality, k-core
membership and betweeness.
Results: A total of 515 (52%) patients established prior contact with at least one
other centre, 126 (13%) with at least two centres, and 20 (2%) with at least three
other centres. The proportion of AUST-01 and AUST-02 infections in patients highly
connected to other centres (contact with at least 1, 2 or 3 centres) was signiﬁcantly
higher (mean: 24%) than patients with no prior centre contact (mean: 12%).
Conclusion: The association of patients with a limited set of centres may support
P. aeruginosa transmission. Capturing patient-centre network connectivity improves
our ability to explain the potential transmission of dominant shared P. aeruginosa
strains.
144 A multiple-locus variable-number tandem repeat analysis
(MLVA) typing scheme developed for genetic ﬁngerprinting
of Burkholderia cenocepacia and applied to nation-wide
epidemiological analysis
C. Segonds1, M. Thouverez2, C. Pourcel3. 1CHU de Toulouse, Observatoire
Cepacia, Laboratoire de Bacte´riologie-Hygie`ne, Toulouse, France; 2CHU de
Besanc¸on, Service d’Hygie`ne Hospitalie`re, Besanc¸on, France; 3Universite´
Paris-Sud, Institut de Ge´ne´tique et Microbiologie, Orsay, France
Objectives: Burkholderia cepacia complex organisms are recognized to be trans-
missible pathogens in CF, requiring epidemiological surveillance. We describe a
MLVA typing scheme for B. cenocepacia which, together with B. multivorans,
accounts for most infections.
Methods: Potential VNTR loci were identiﬁed upon analysis of the annotated
genome sequences of strain AU1054, J2315 and MCO-3, and 10 of them were
selected on the basis of polymorphism and repeat size. A collection of 100
B. cenocepacia isolates (49 IIIA, 41 IIIB, 8 IIIC and 2 IIID), including 75 clinical
isolates from the Observatoire cepacia collection, and 25 reference strains, was used
to evaluate typeability, epidemiological concordance and discriminatory power of
MLVA, compared with PCR-ribotyping, PFGE, and, if discordant, with MLST.
Stability was assessed by testing 39 successive isolates from 13 patients.
Results: Typeability ranged from 91 to 100%, except for 1 marker, which was
not ampliﬁed in 53% of IIIA isolates. Allelic variation was more important within
IIIB than within IIIA isolates. The analysis of 39 epidemiologically related strains
demonstrated complete epidemiological concordance. Discriminatory power was
assessed comparing 59 epidemiologically unrelated isolates, which were distributed
in 28 unique MLVA types and 10 shared types, among which 4 belonged to globally
distributed lineages (ST32, ST122, ST234, ST241). MLVA types were shown to be
stable in 11 patients, whereas a single locus variation was observed in 2 patients.
Conclusion: MLVA appears to be a promising cost-effective method for B. ceno-
cepacia population analysis. The development of a MLVA scheme for B. multivorans
is in progress.
145 The prevalence and signiﬁcance of methicillin resistant
Staphylococcus aureus infection in patients with cystic ﬁbrosis
in a Macedonian CF center
S. Fustik1, T. Jakovska1, S. Lidija1. 1University Children’s Clinic, Skopje,
Macedonia, the Former Yugoslav Republic of
Objectives: Pulmonary infection with MRSA is an increasing problem for patients
with CF over the past decade. The objectives of this study were to determine
the prevalence of MRSA infection in a Macedonian CF center and the impact of
chronic MRSA colonization on lung function and nutritional status. The efﬁcacy
of our eradication strategy was also assessed.
Methods: A retrospective review of all MRSA-positive patients from 2007 to 2012
was undertaken. Chronic infection was deﬁned as persistently or 3 consecutive
MRSA-positive respiratory cultures during at least 6 months follow-up period.
Data collected included FVC, FEV1, and standard deviation score for weight for
height (zW/H), prior and two years after MRSA diagnosis. MRSA eradication was
attempted with two oral antibiotics for 4 weeks and nebulised Vancomycin for
2 weeks.
Results: Of 110 CF patients (aged 1−31 years), 37 (33.6%) were identiﬁed as
having respiratory cultures positive for MRSA at some point in time. Mean age at
ﬁrst acquisition of MRSA was 8.6±5.9 years. 14 have developed chronic infection,
thus, successful eradication was achieved in 62% of patients. The prevalence of
chronic MRSA colonization in our CF population amounted to 12.7%. Mean FVC,
FEV1 and zW/H values, prior and two years after MRSA colonization, in this group
were: 91.9±21.1 vs 92.3±20.6; 89.7±24.2 vs 82.8±23.2; −0.09±0.8 vs −0.02±0.7,
respectively. The differences were not signiﬁcant.
Conclusions: Chronic MRSA infection has neutral or deleterious effects in patients
with more severe lung disease. High prevalence of MRSA infection in our center
indicate the needs for enhanced segregation, infection control policy and eradication
treatment.
146 Trombones − A potential source of recurrent Burkholderia
cepacia complex infection?
M. Denton1, C. Etherington2, D. Peckham2. 1Leeds Teaching Hospitals NHS
Trust, Microbiology, Leeds, United Kingdom; 2Leeds Teaching Hospitals NHS
Trust, Adult CF Unit, Leeds, United Kingdom
Objectives: Burkholderia cepacia complex (Bcc) is a signiﬁcant cause of morbidity
and mortality in people with cystic ﬁbrosis (CF). Infection with some members
of the Bcc (e.g. Burkholderia cenocepacia) can also be a contra-indication to
transplantation. We report a case of recurrent Burkholderia cenocepacia IIIB (BC
IIIB) infection in which a trombone was implicated as a potential source of
recurrence.
Methods: In February 2009 a routine sputum sample from 48 year old male with CF
grew BC IIIB. The identity was conﬁrmed by recA sequencing. Eradication therapy
was commenced immediately and he received two weeks of intravenous amikacin,
meropenem and ceftazidime in combination, all three of which the isolate was
susceptible to. This was followed by a further three months of aerosolised amikacin
which stopped in June 2009. Over the next year the patient submitted 11 sputum
samples, all of which were negative for Bcc. However, in July 2010 a sputum
sample again grew BC IIIB. Despite further attempts to eradicate the organism
it persisted and he was still sputum-positive for BC IIIB in October 2012. The
subject was noted to be a keen trombone player. In August 2010 the instrument
was sampled. Although samples from the mouthpiece and bell failed to yield BC
IIIB, the organism was isolated from the spit valve.
Conclusion: Musical instruments could be a potential source of recurrent Bcc in-
fection in people with CF. Consideration should be given to the proper cleaning and
maintenance of musical instruments, particularly in those undergoing eradication
therapy for CF-associated pathogens.
